Exploring the Therapeutic Potential of Metformin in Polycystic Ovary Syndrome: Focusing on Hyperandrogenism in a Sample of Iraqi Women
September 2025
in “
Reproductive health of woman
”
Studysummary This study found that in women with polycystic ovary syndrome, taking metformin for three months significantly reduced serum levels of luteinizing hormone, follicle-stimulating hormone, and testosterone, suggesting a beneficial effect on managing hyperandrogenism.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on repro-health.com.ua →